FirmaLab
Firmalab Bio-Diagnostics is a leading diagnostic clinical laboratory dedicated to providing accurate, timely, and comprehensive molecular diagnostics and testing services. With a focus on innovation and state-of-the-art technology, they serve healthcare providers, corporations, and research institutions nationwide, offering a wide range of tests including genomics, pharmacogenetics, infectious diseases, toxicology, and wound infection testing. Their mission is to support healthcare decisions and improve patient outcomes through high-quality diagnostic solutions.
Industries
Nr. of Employees
small (1-50)
FirmaLab
Los Angeles, California, United States, North America
Products
PGx self-collection test kit
Patient kit for pharmacogenetics testing containing buccal/saliva collection swabs, barcode label, return mailer with prepaid shipping, and user instructions for remote specimen collection.
Wound pathogen and antibiotic resistance panel
Real-time RT-PCR panel for comprehensive detection of bacterial, fungal and viral wound pathogens (28 targets) plus screening for a panel of antibiotic resistance genes (28 targets); validated sensitivity/specificity and 24–48 hour turnaround.
Mini Respiratory Panel
A 3 targets in 1 test for FluA, FluB, and COVID-19.
Mini Respiratory Panel (COVID-19/Flu)
Our Mini Respiratory Panel is a rapid, reliable testing solution for respiratory infections, including COVID-19, Flu, and RSV, using real-time RT-PCR technology.
UTI Pathogen Detection and Antibiotic Resistance Molecular Assay
An advanced molecular assay performed on an open array platform using Real-Time PCR technology for detecting common uropathogens and associated antibiotic resistance genes.
SARS-CoV-2 Molecular Assay
Real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid of SARS-CoV-2 from upper and lower respiratory specimens.
PGx self-collection test kit
Patient kit for pharmacogenetics testing containing buccal/saliva collection swabs, barcode label, return mailer with prepaid shipping, and user instructions for remote specimen collection.
Wound pathogen and antibiotic resistance panel
Real-time RT-PCR panel for comprehensive detection of bacterial, fungal and viral wound pathogens (28 targets) plus screening for a panel of antibiotic resistance genes (28 targets); validated sensitivity/specificity and 24–48 hour turnaround.
Mini Respiratory Panel
A 3 targets in 1 test for FluA, FluB, and COVID-19.
Mini Respiratory Panel (COVID-19/Flu)
Our Mini Respiratory Panel is a rapid, reliable testing solution for respiratory infections, including COVID-19, Flu, and RSV, using real-time RT-PCR technology.
UTI Pathogen Detection and Antibiotic Resistance Molecular Assay
An advanced molecular assay performed on an open array platform using Real-Time PCR technology for detecting common uropathogens and associated antibiotic resistance genes.
SARS-CoV-2 Molecular Assay
Real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid of SARS-CoV-2 from upper and lower respiratory specimens.
Services
Laboratory testing for respiratory (COVID/Flu/RSV), UTI with ABR, and STI panels using real-time RT-PCR and other molecular assays; includes sample processing, reporting and turnaround service levels.
Comprehensive toxicology workflow including presumptive drug screens and LC-MS/MS confirmatory testing across urine and oral matrices, specimen validity testing, and longitudinal reporting for medication management.
PGx panel testing for medication optimization (cardiovascular, pain, oncology, psychotropic, comprehensive) with sample kit distribution, laboratory analysis, report generation and clinical interpretation support.
Targeted gene and diagnostic sequencing services, including single-exon, multi-exon and disease-specific panels using Sanger sequencing and sequential testing strategies.
Managed testing programs for large organizations including sample collection coordination, transportation logistics, outbreak management and result integration.
Interpretive reporting service that integrates ABR gene detection with guideline-based pharmacotherapy recommendations and PharmD review to guide antibiotic selection.
Laboratory testing for respiratory (COVID/Flu/RSV), UTI with ABR, and STI panels using real-time RT-PCR and other molecular assays; includes sample processing, reporting and turnaround service levels.
Comprehensive toxicology workflow including presumptive drug screens and LC-MS/MS confirmatory testing across urine and oral matrices, specimen validity testing, and longitudinal reporting for medication management.
PGx panel testing for medication optimization (cardiovascular, pain, oncology, psychotropic, comprehensive) with sample kit distribution, laboratory analysis, report generation and clinical interpretation support.
Targeted gene and diagnostic sequencing services, including single-exon, multi-exon and disease-specific panels using Sanger sequencing and sequential testing strategies.
Managed testing programs for large organizations including sample collection coordination, transportation logistics, outbreak management and result integration.
Interpretive reporting service that integrates ABR gene detection with guideline-based pharmacotherapy recommendations and PharmD review to guide antibiotic selection.
Expertise Areas
- Infectious disease molecular diagnostics
- Toxicology and confirmatory drug testing
- Pharmacogenetics and precision medicine
- Clinical genomics and targeted sequencing
Key Technologies
- Real-time RT-PCR
- Multiplex PCR
- Sanger sequencing
- Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
News & Updates
A specialist will review your inquiry and get back within 24 hours, providing detailed information and resources.
A specialist will review your inquiry and get back within 24 hours, providing detailed information and resources.